Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Clinical trial NCT05384821 · RECRUITING
Trial details
- NCT number
- NCT05384821
- Sponsor
- Centre Oscar Lambret
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-14
- Primary completion
- 2028-05-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.